Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment: A Multi-center Randomized Trial

NCT00392054 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.

NCT NCT00392054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00392054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment: A Multi-center Randomized Trial
Lead sponsor
Population Health Research Institute
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2006
Completion date
February 29, 2012
Enrollment
127 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation